Firas Zahr and Dr. C Michael Gibson Discuss: CLASP IID 2 YearRCT and Registry: Two-Year Outcomes of Transcatheter Edge-to-Edge Repair for Degenerative Mitral Regurgitation October 30, 2024 Disclosures: TBD
Birgitte Krogsgaard Andersen and Niels Ramsing Holm and Dr. C Michael Gibson Discuss: FAVOR III EuropeQuantitative Flow Ratio or Fractional Flow Reserve for Guiding Coronary Revascularization October 30, 2024 Disclosures: TBD
Ajay J. Kirtane and Dr. C Michael Gibson Discuss: ECLIPSEA Large-Scale, Randomized Trial of Orbital Atherectomy vs. Conventional Balloon Angioplasty in Severely Calcified Coronary Arteries Prior to DES Implantation October 29, 2024 Disclosures: TBD
Alexander Van Rosendael and Dr. C Michael Gibson Discuss: CONFIRM-2Artificial Intelligence Enabled Quantitative CT Assessment of Atherosclerosis and Major Adverse Events: A Multi-Center International Registry October 28, 2024 Disclosures: TBD
David Erlinge and Dr. C Michael Gibson Discuss: INFINITY-SWEDEHEART Complex PCI1-Year and Landmark 6–12 Month Clinical Outcomes Among Patients With Complex Lesion Subsets Treated with DynamX Bioadaptor Compared to a Contemporary Drug Eluting Stent October 28, 2024 Disclosures: TBD
Marc Dweck and Dr. C Michael Gibson Discuss: EVOLVEDEarly Intervention in Patients With Asymptomatic Severe Aortic Stenosis and Left Ventricular Myocardial Fibrosis October 28, 2024 Disclosures: TBD
Philippe Genereux and Dr. C Michael Gibson Discuss: Early TAVRTranscatheter Aortic Valve Replacement for Asymptomatic Severe Aortic Stenosis: Results of the EARLY TAVR Trial October 28, 2024 Disclosures: TBD
Dr. Siddharth Patel and Dr. C Michael Gibson Discuss: Long-acting Factor XI Inhibition and Periprocedural Bleeding: A Secondary Analysis from AZALEA-TIMI 71 September 2, 2024 Disclosures: TBD
Dr. Byeong-Keuk Kim and Dr. C Michael Gibson Discuss: OCCUPI – Optical coherence tomography-guided coronary intervention in patients with complex lesions September 2, 2024
Dr. C Michael Gibson and Serge Korijan Discuss: Apolipoprotein A-I infusions and cardiovascular outcomes in patients with acute myocardial infarction and hyperlipidemia, ApoA-I Infusions and Burden of Ischemic Events after Acute Myocardial Infarction September 2, 2024 Disclosures: TBD
